par Minisini, A;Atalay, G;Bottomley, A;Puglisi, Fabio;Piccart-Gebhart, Martine 
;Biganzoli, Laura
Référence Lancet oncology, 5, 5, page (273-282)
Publication Publié, 2004-05
;Biganzoli, Laura Référence Lancet oncology, 5, 5, page (273-282)
Publication Publié, 2004-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Minisini, A; Atalay, G; Bottomley, A; Puglisi, Fabio; Piccart-Gebhart, Martine; Biganzoli, Laura |
| Informations sur la publication: | Lancet oncology, 5, 5, page (273-282) |
| Statut de publication: | Publié, 2004-05 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antineoplastic Agents -- adverse effects |
| Brain -- drug effects | |
| Cognition Disorders -- chemically induced | |
| Estrogens -- adverse effects | |
| Humans | |
| Interferon-alpha -- adverse effects | |
| Interleukin-2 -- adverse effects | |
| Neoplasms -- drug therapy | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1470-2045 |
| info:doi/10.1016/S1470-2045(04)01465-2 | |
| info:pii/S1470204504014652 | |
| info:scp/2142816687 | |
| info:pmid/15120664 |
